Scotiniotis I A, Lucey M R, Metz D C
Division of Gastroenterology, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Dig Dis Sci. 2001 Dec;46(12):2744-51. doi: 10.1023/a:1012787731821.
The importance of ammonia-producing Helicobacter pylori infection as a cause of subclinical encephalopathy in cirrhosis was investigated. In addition, a single psychometric test that can reliably detect subclinical hepatic encephalopathy was sought. Out-patients with cirrhosis and no overt encephalopathy underwent [14C]urea breath testing once and psychometric testing on two separate occasions, with an intervening course of clarithromycin/omeprazole if they had subclinical encephalopathy (two of four psychometric tests abnormal). Subclinical encephalopathy was present in 27 of 69 patients (39%), and Helicobacter pylori infection in 14 of 69 (20%). There was no association between the two conditions (P = 0.769). Subclinical encephalopathy resolved in 75% of treated Helicobacter pylori-positive patients and 37.5% of treated Helicobacter pylori-negative patients (P = 0.285). Number connection test-B had high reproducibility among untreated patients (R = 0.655) and high correlation (P < or = 0.01) with three surrogate gold standards. In stable cirrhotic patients, subclinical hepatic encephalopathy was found to: (1) have a high prevalence, (2) not be associated with Helicobacter pylori infection, and (3) be readily detected with the number connection test-B alone.
研究了产氨幽门螺杆菌感染作为肝硬化亚临床脑病病因的重要性。此外,还寻求一种能够可靠检测亚临床肝性脑病的单一心理测量测试。肝硬化且无明显脑病的门诊患者接受了一次[14C]尿素呼气试验,并在两个不同时间进行心理测量测试,如果他们患有亚临床脑病(四项心理测量测试中有两项异常),则接受克拉霉素/奥美拉唑的干预疗程。69例患者中有27例(39%)存在亚临床脑病,69例中有14例(20%)存在幽门螺杆菌感染。这两种情况之间无关联(P = 0.769)。75%的幽门螺杆菌阳性治疗患者和37.5%的幽门螺杆菌阴性治疗患者的亚临床脑病得到缓解(P = 0.285)。数字连接试验-B在未治疗患者中具有高重复性(R = 0.655),且与三项替代金标准具有高度相关性(P≤0.01)。在稳定的肝硬化患者中,发现亚临床肝性脑病:(1)患病率高,(2)与幽门螺杆菌感染无关,(3)仅通过数字连接试验-B即可轻松检测到。